Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook
Summary
Novo reported better-than-expected quarterly earnings on Wednesday, driven by strong sales of its Wegovy pill. Following these results, the pharmaceutical company increased its financial outlook for the full year.
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates
Source: Read the full story at US Top News and Analysis
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.